Safety and Feasibility of PARP1/2 Imaging with <sup>18</sup>F-PARPi in Patients with Head and Neck Cancer.

导出 OA

翻译打印收藏纠错

第一作者： Heiko,Schöder

第一单位： Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. reinert@mskcc.org schoderh@mskcc.org.

作者： Heiko,Schöder ^[1] ; Paula Demétrio De Souza,França ^[2] ; Reiko,Nakajima ^[3] ; Eva,Burnazi ^[4] ; Sheryl,Roberts ^[3] ; Christian,Brand ^[5] ; Milan,Grkovski ^[3] ; Audrey,Mauguen ^[3] ; Mark P,Dunphy ^[6] ; Ronald A,Ghossein ^[7] ; Serge K,Lyashchenko ^[3] ; Jason S,Lewis ^[2] ; Joseph A,O'Donoghue ^[8] ; Ian,Ganly ^[3] ; Snehal G,Patel ^[2] ; Nancy Y,Lee ^[5] ; Thomas,Reiner ^[3]

作者单位： Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. reinert@mskcc.org schoderh@mskcc.org. ^[1] Department of Radiology, Weill Cornell Medical College, New York, New York. ^[2] Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. ^[3] Department of Otorhinolaryngology and Head and Neck Surgery, Federal University of São Paulo, São Paulo, Brazil. ^[4] Radiochemistry and Molecular Imaging Probes Core, Memorial Sloan Kettering Cancer Center, New York, New York. ^[5] Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York. ^[6] Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. ^[7] Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. ^[8] Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York. ^[9] Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York. ^[10] Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. ^[11] Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York. ^[12]